New Jersey · 2026-2027 Regular Session · Bill
A 4184: Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
A 4184 is a bill introduced in the New Jersey House on February 19, 2026. According to its official title, it concerns: Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products. Primary sponsor: Carol Murphy (Democratic). Most recent recorded action (February 19, 2026): Introduced, Referred to Assembly Health Committee.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Carol Murphy | Primary sponsor | Democratic | House | 7 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Introduced, Referred to Assembly Health Committee